News

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush ...
A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...
New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric ...
Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.
Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...
Help is now there for those diagnosed with hard-to-treat blood cancers like leukemia and lymphoma, as new therapies are ...
A Honduran woman filed a lawsuit challenging the legality of her and her family’s detention at a Texas facility. She is also ...
Numerous businesses in Acadiana have come together for a benefit being held in support of a local boy, Fisher, and his family ...
Shelley Garvey blamed her fatigue and headaches on a slow recovery from a virus. It turned out to be a rare form of cancer.
Aggressive forms of acute myeloid leukemia (AML) remain challenging to treat, especially in patients with FLT3-ITD mutations.
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a ...